Aquestive Therapeutics, Inc. (AQST) › Cash & EquivalentsAquestive Therapeutics, Inc. (AQST) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2016-12-31: $9.21M2017-12-31: $17.38M2018-12-31: $60.60M2019-12-31: $49.33M2020-12-31: $31.81M$31.81M2016-12-31Cash & Equivalents (USD)2020-12-31Period endedCash & EquivalentsChange YoYSource filing2020-12-31$31.81M-35.5%2021-03-09Balance as of period end2019-12-31$49.33M-18.6%2021-03-09Balance as of period end2018-12-31$60.60M+248.7%2020-03-11Balance as of period end2017-12-31$17.38M+88.7%2019-03-14Balance as of period end2016-12-31$9.21M—2019-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)